News

Published on 18 Feb 2025 on Zacks · via Yahoo Finance

NeoGenomics (NEO) Tops Q4 Earnings Estimates

Article preview image

NeoGenomics (NEO) delivered earnings and revenue surprises of 100% and 0.92%, respectively, for the quarter ended December 2024. Do the numbers hold...

Read the rest of the article
NASDAQ.NEO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
NeoGenomics (NEO) Tops Q4 Earnings Estimates

NeoGenomics (NEO) delivered earnings and revenue surprises of 100% and 0.92%, respectively, for t...

Zacks · via Yahoo Finance 18 Feb 2025
Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of...

While not a mind-blowing move, it is good to see that the NeoGenomics, Inc. (NASDAQ:NEO) share pr...

Simply Wall St. · via Yahoo Finance 26 Jan 2025
Natera president sells $4.1 million in stock By Investing.com

AUSTIN, Texas—Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA)...

Investing.com 25 Jan 2025
Natera's CFO Michael Burkes sells $247,378 in stock By Investing.com

Natera's CFO Michael Burkes sells $247,378 in stock

Investing.com 25 Jan 2025
Natera's chief legal officer sells $3.64 million in stock By Investing.com

Daniel Rabinowitz, the Secretary and Chief Legal Officer of Natera, Inc. (NASDAQ:NTRA), a company...

Investing.com 23 Jan 2025
Why Is Andreas Halvorsen Bullish On Ameriprise Financial, Inc. (AMP) Now?

We recently compiled a list of the Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks. ...

Insider Monkey · via Yahoo Finance 23 Jan 2025
Natera CEO Steven Chapman sells $12.96m in stock By Investing.com

The filing also indicates that Chapman acquired shares through the exercise of restricted stock...

Investing.com 23 Jan 2025
Natera co-founder Sheena Jonathan sells $160,214 in stock By Investing.com

AUSTIN, TX—Sheena Jonathan, co-founder and director of Natera, Inc. (NASDAQ:NTRA), a company whos...

Investing.com 23 Jan 2025
NeoGenomics stock rises on upbeat 2025 financial outlook By Investing.com

NeoGenomics stock rises on upbeat 2025 financial outlook

Investing.com 16 Jan 2025
NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. T...

Zacks · via Yahoo Finance 15 Jan 2025

Copyright Statfolio @ 2025

Social Accounts